Focal segmental glomerulosclerosis and Oedema

Summary:

Oedema is found among people with Focal segmental glomerulosclerosis, especially for people who are female, 10-19 old.

The study analyzes which people have Oedema with Focal segmental glomerulosclerosis. It is created by eHealthMe based on reports of 33 people who have Focal segmental glomerulosclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Focal segmental glomerulosclerosis?

Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli) is found to be associated with 176 drugs and 396 conditions by eHealthMe. Check the latest studies of Focal segmental glomerulosclerosis.

What is Oedema?

Oedema (fluid collection in tissue) is found to be associated with 2,215 drugs and 2,311 conditions by eHealthMe. Check the latest studies of Oedema.



On Jul, 14, 2026

33 people who have Focal Segmental Glomerulosclerosis and Oedema are studied.

Would you have Oedema when you have Focal segmental glomerulosclerosis?

Gender of people who have Focal Segmental Glomerulosclerosis and experienced Oedema *:

  • female: 53.12 %
  • male: 46.88 %

Age of people who have Focal Segmental Glomerulosclerosis and experienced Oedema *:

  • 0-1: 13.04 %
  • 2-9: 0.0 %
  • 10-19: 34.78 %
  • 20-29: 4.35 %
  • 30-39: 26.09 %
  • 40-49: 0.0 %
  • 50-59: 4.35 %
  • 60+: 17.39 %

Common co-existing conditions for these people *:

  1. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 16 people, 48.48%
  2. High Blood Cholesterol: 5 people, 15.15%
  3. High Blood Pressure: 5 people, 15.15%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.12%
  5. Pain: 3 people, 9.09%
  6. Nephrosclerosis (hardening of the kidney due to renovascular disease): 3 people, 9.09%
  7. Blood Potassium Decreased: 2 people, 6.06%
  8. Blood Pressure Abnormal: 2 people, 6.06%
  9. Bone Loss: 2 people, 6.06%
  10. Swelling: 2 people, 6.06%

Common drugs taken by these people *:

  1. Prednisolone: 11 people, 33.33%
  2. Cyclosporine: 7 people, 21.21%
  3. Amlodipine: 6 people, 18.18%
  4. Cyclophosphamide: 6 people, 18.18%
  5. Vitamin D: 4 people, 12.12%
  6. Ciclosporin: 4 people, 12.12%
  7. Lasix: 4 people, 12.12%
  8. Lipitor: 3 people, 9.09%
  9. Captopril: 3 people, 9.09%
  10. Prograf: 3 people, 9.09%

Common symptoms for these people *:

  1. High Blood Pressure: 7 people, 21.21%
  2. Purulent Discharge (discharge that contains pus): 7 people, 21.21%
  3. Fatigue (feeling of tiredness): 6 people, 18.18%
  4. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 6 people, 18.18%
  5. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 5 people, 15.15%
  6. Weight Increased: 5 people, 15.15%
  7. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 5 people, 15.15%
  8. Rashes (redness): 5 people, 15.15%
  9. White Blood Cell Count Increased: 4 people, 12.12%
  10. Cerebral Disorder (brain disease): 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Oedema?

- Check whether Oedema is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Oedema:

All the conditions that are associated with Oedema:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Oedema and Focal segmental glomerulosclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: